Claudia Proto
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) (NCT03921671) | Claudia Proto | 2018-11-01 |
Track Claudia Proto automatically
Every clearance here is in the API, with alerts when new ones post.